Skip to content

Safety and efficacy of extracorporeal physical vibration lithotripsy (EPVL) in the treatment of children with upper urinary tract stones: a multicenter, prospective, randomized controlled study

Safety and efficacy of extracorporeal physical vibration lithotripsy (EPVL) in the treatment of children with upper urinary tract stones: a multicenter, prospective, randomized controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040411
Enrollment
Unknown
Registered
2020-11-28
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urinary tract stone

Interventions

Experimental group:Physical Vibration
Control Group:none

Sponsors

The Second Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Patients and their guardians voluntarily participated in the trial and signed informed consent; 2. The age ranged from 1 to 14 years old; 3. Renal or ureteral calculi with definite imaging diagnosis; 4. Patients after extracorporeal shock wave lithotripsy or ureteroscopic lithotripsy; 5. The diameter of untreated upper urinary tract stones <6 mm; 6. There was no obstruction of the urinary tract below the stone, or the stone did not cause complete obstruction of the urinary tract; 7. Normal renal function: normal range of serum creatinine and serum urea nitrogen; 8. No urinary system malformation: horseshoe kidney, solitary kidney, duplication of kidney, etc.

Exclusion criteria

Exclusion criteria: 1. Combined with severe heart and lung dysfunction, important organ failure or bleeding / coagulation abnormalities, they could not tolerate extracorporeal physical lithotripsy; 2. Urinary malformation, ureteral stricture or obstruction; 3. The patients were complicated with uncontrolled urinary tract infection; 4. Combined with severe hydronephrosis, urinary tract malformation.

Design outcomes

Primary

MeasureTime frame
Security;

Secondary

MeasureTime frame
Effectiveness;

Countries

China

Contacts

Public ContactXu Changbao

The Second Affiliated Hospital of Zhengzhou University

xcb1966@126.com+86 15303729717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026